Literature DB >> 16574552

Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.

Anna Ceribelli1, Fabiana Letizia Cecere, Michele Milella, Francesco Facciolo, Alain Gelibter, Francesco Cognetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16574552     DOI： 10.1016/S1470-2045(06)70662-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Muscle spasms: an unexpected adverse drug reaction of pemetrexed?

Authors:  Hendrika J A de Rouw; Naomi T Jessurun; Lucie J P Masen-Poos; Hieronymus J Derijks
Journal:  Ther Adv Med Oncol       Date:  2016-11-21       Impact factor: 8.168

2.  Severe acute rhabdomyolysis induced by multi-agent chemotherapy for alveolar rhabdomyosarcoma in a 15-year-old female: a case report.

Authors:  Hiroshi Matsuzaki; Yuhki Koga; Aiko Suminoe; Utako Oba; Tomohito Takimoto; Toshiro Hara
Journal:  Case Rep Oncol       Date:  2013-07-31

3.  Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.

Authors:  Alexandra Sokolova; Onyee Chan; Waqas Ullah; Auon Abbas Hamdani; Faiz Anwer
Journal:  J Med Case Rep       Date:  2017-04-11

4.  Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

Authors:  G L Ceresoli; B Castagneto; P A Zucali; A Favaretto; M Mencoboni; F Grossi; D Cortinovis; G Del Conte; A Ceribelli; A Bearz; S Salamina; F De Vincenzo; F Cappuzzo; M Marangolo; V Torri; A Santoro
Journal:  Br J Cancer       Date:  2008-06-10       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.